|
|
|
|
|
|
|
|
|
|
"PD 407824 is only available for laboratory research, but other drugs inhibiting CHEK1 are already used to treat patients in the clinic," said Dr. Raoul Tibes, one of the paper's senior a co-authors and an Associate Investigator in TGen's Clinical Translational Research Division. "
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.